• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Rev Clin Esp. Distributions of time, place, and population of novel coronavirus disease 2019 (COVID-19) from January 20 to February 10, 2020, in China

tetano

Editor, Senior Moderator
Rev Clin Esp. 2020 Apr 10. doi: 10.1016/j.rce.2020.04.001. [Epub ahead of print]
[Distributions of time, place, and population of novel coronavirus disease 2019 (COVID-19) from January 20 to February 10, 2020, in China].


[Article in Spanish]

Jin L[SUP]1[/SUP], Zhao Y[SUP]2[/SUP], Zhou J[SUP]2[/SUP], Tao M[SUP]2[/SUP], Yang Y[SUP]3[/SUP], Wang X[SUP]3[/SUP], Ye P[SUP]4[/SUP], Shan S[SUP]5[/SUP], Yuan H[SUP]2[/SUP].

Author information




Abstract

BACKGROUND AND OBJECTIVE:

Since December 2019, increasing cases of novel coronavirus disease 2019 (COVID-19) are being detected worldwide. The purpose of this paper is to provide a scientific reference for the global prevention and control of COVID-19.
METHODS:

General demographic characteristics, epidemiological history, and clinical symptoms of COVID-19 were collected that had been reported on the websites of multiple Municipal Health Commissions in China. We herein describe distributions in time, place, and population of COVID-19.
RESULTS:

As of midnight on February 10, 2020, the number of confirmed cases of COVID-19 in China was 42,638, and the province with the largest number of confirmed cases was Hubei (31728), followed by Guangdong (1177), Zhejiang (1117), and Henan (1105) province. The number of cases and the speed of confirmed cases in provinces other than Hubei were more moderate than those of the Hubei province. The median (interquartile range) age of 1740 patients with COVID-19 was 44 (33, 54) years, with a range of 10 months to 89 years.
CONCLUSIONS:

The COVID-19 epidemic should be considered a global threat and the steps for control include early diagnosis and treatment, as well as isolation.
? 2020 Elsevier Espa?a, S.L.U. and Sociedad Espa?ola de Medicina Interna (SEMI). All rights reserved.



KEYWORDS:

Infectious diseases; Novel coronavirus; Outbreak; Pneumonia


PMID:32292205PMCID:PMC7151366DOI:10.1016/j.rce.2020.04.001
Free PMC Article
 
Back
Top Bottom